Vaccines

28 Jul 2008 Nventa Announces Final Data From HSPE7 Phase I Cervical Dysplasia Trial
23 Jul 2008 Nabi Biopharmaceuticals Announces Positive Interim Results of NicVAX Immunogenicity Study
22 Jul 2008 Opexa Conducts Additional Analysis on Phase I/II Extension Study with Tovaxin(R) for Multiple Sclerosis
18 Jul 2008 Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID(R) Demonstrates Clinically and Statistically Significant Improvement of Disease-Free Survival in Non-Hodgkin's Lymphoma in Pivotal Phase 3 Clinical Trial
16 Jul 2008 AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine
13 Jul 2008 Oxford BioMedica Announces Data Safety Monitoring Board Reccomendation for TroVax(R) Phase III Trist Study
10 Jul 2008 CYT003-QbG10 monotherapy for the treatment of allergic diseases is safe and efficacious in placebo-controlled phase II study
10 Jul 2008 Investigational New Drug Application Submitted On Behalf of Generex Biotechnology for Combination Immunotherapy Vaccine Trials
08 Jul 2008 Opexa’s Phase IIb Study of Tovaxin(R) Receives Positive Review from Data Safety Monitoring Board
08 Jul 2008 Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU
01 Jul 2008 IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
30 Jun 2008 GlaxoSmithKline responds to FDA on Cervarix(R) and plans to submit final study data for approval
30 Jun 2008 Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine
29 Jun 2008 Greer Completes Enrollment for Pivotal Phase III Clinical Trial Evaluating the Efficacy of Sublingual-Oral Immunotherapy for Treating Short Ragweed Allergies
25 Jun 2008 Medicago's H5N1 VLP Vaccine Demonstrates Cross-Reactivity Against Multiple Strains of Avian Flu in Key Ferret Animal Model
19 Jun 2008 Bavarian Nordic reports interim data from Phase I/II studies with breast cancer vaccine
18 Jun 2008 Nventa Develops Proprietary Vaccine adjuvant
17 Jun 2008 CSL Receives TGA Approval to Register Panvax(R), Avian Flu Vaccine
16 Jun 2008 Vical Pandemic Influenza Vaccines Provide Complete Protection in Animal Studies; The Journal of Infectious Diseases Publishes H5N1 Challenge Data
12 Jun 2008 Opexa Therapeutics Reports Favorable Two-Year Data in Phase I/II Retreatment Studies of Tovaxin(R) for Multiple Sclerosis
12 Jun 2008 Phase III data show GSK paediatric candidate vaccine’s potential to provide improved protection against life-threatening pneumococcal diseases
12 Jun 2008 Promising Data Presented on Genvec Malaria Vaccine Program
08 Jun 2008 Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate
04 Jun 2008 NIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine
04 Jun 2008 Reduced Hepatitis C Viral Level Achieved with DNA Vaccine Delivered by Inovio Biomedical's Electroporation Delivery System in Phase I/II Clinical Study

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top